Industry / Croatia
Reimbursement Spending Increases, Debts Remain
December 2007 | Industry NewsCroatia increased its expenditure on reimbursed drugs by 4.2% in 2006, an outcome that BMI views as surprising considering that we expected most of the mandated 7% budget increase for the year to go on paying previously accumulated debts related to pharmaceutical purchases.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
